Furthermore, recent studies have shown that the activation of B-cell receptor (BCR) signaling could be associated with good prognoses in various cancers, such as breast cancer and lung cancer, by generating humoral immune responses via TIBs, resulting in effective anti-tumor immunity at the tumor site [52,53]. The gene discussed is BCR; the disease is cancer.